Register entryShortage reported

Milla Pharmaceuticals Inc.

Registered sites
0
Drug products
7
Live patents
0
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Alert

Products in shortage

4
DrugPresentationAvailability
Sodium Acetate InjectionSodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10)Limited Availability
Sodium Acetate InjectionSodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)Available
Sodium Acetate InjectionSodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)Available
Sodium Acetate InjectionSodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)Available
Catalogue

Marketed products

7

Showing 7 of 7.

BrandGeneric nameFormCategory
Dihydroergotamine MesylateDihydroergotamine MesylateINJECTION, SOLUTIONANDA
Sodium AcetateSodium AcetateINJECTION, SOLUTION, CONCENTRATEANDA
Sodium AcetateSodium AcetateINJECTION, SOLUTION, CONCENTRATEANDA
Sodium AcetateSodium Acetate Injection, USP, 200 mEq/100 mLINJECTION, SOLUTION, CONCENTRATEANDA
Sodium AcetateSodium Acetate Injection, USP, 400 mEq/100 mLINJECTION, SOLUTION, CONCENTRATEANDA
Sodium BicarbonateSodium BicarbonateINJECTION, SOLUTIONANDA
TromethamineTromethamineINJECTION, SOLUTIONANDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.